APPB (Applied Biosciences) Beneish M-Score: 0.00 (As of Jun. 26, 2026)

What is Applied Biosciences Beneish M-Score?

Applied Biosciences APPB 12 Beneish M-Score is 0.00 as of Jun. 26, 2026. GuruFocus rates APPB with a GF Score™ of 12/100.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Applied Biosciences's Beneish M-Score or its related term are showing as below:

During the past 5 years, the highest Beneish M-Score of Applied Biosciences was 0.00. The lowest was 0.00. And the median was 0.00.

Applied Biosciences Beneish M-Score Related Terms

Applied Biosciences Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Applied Biosciences's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Applied Biosciences Beneish M-Score Chart

Applied Biosciences Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Beneish M-Score

0.00

Applied Biosciences Quarterly Data
	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19
Beneish M-Score	Get a 7-Day Free Trial															-9.05	0.00	0.14	0.75	-4.59

APPB vs CNABQ, OWCP, CXUS: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Applied Biosciences's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Applied Biosciences Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Applied Biosciences's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Applied Biosciences's Beneish M-Score falls into.

Save Embed

12GF Score

Applied Biosciences Corp APPB

Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Applied Biosciences Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Applied Biosciences for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 * 2.4057

0.528 * 0.1228

0.404 * 0.9341

0.892 * 1.7551

0.115 * 4.4116

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 * 0.5812

4.679 * -0.497659

0.327 * 6.5969

-4.70

This Year (Dec19) TTM:

Last Year (Dec18) TTM:

Total Receivables was $0.08 Mil.
Revenue was 0.17 + 0.244 + 0.211 + 0.235 = $0.86 Mil.
Gross Profit was 0.118 + 0.146 + 0.112 + 0.153 = $0.53 Mil.
Total Current Assets was $0.21 Mil.
Total Assets was $3.42 Mil.
Property, Plant and Equipment(Net PPE) was $0.68 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.18 Mil.
Selling, General, & Admin. Expense(SGA) was $3.05 Mil.
Total Current Liabilities was $2.02 Mil.
Long-Term Debt & Capital Lease Obligation was $0.26 Mil.
Net Income was -1.353 + -0.778 + -0.424 + -0.232 = $-2.79 Mil.
Non Operating Income was -0.367 + 0.004 + 0 + 0.211 = $-0.15 Mil.
Cash Flow from Operations was -0.052 + -0.367 + -0.399 + -0.116 = $-0.93 Mil.

Total Receivables was $0.02 Mil.
Revenue was 0.413 + 0.049 + 0.01 + 0.018 = $0.49 Mil.
Gross Profit was 0.034 + 0.007 + -0.007 + 0.003 = $0.04 Mil.
Total Current Assets was $0.38 Mil.
Total Assets was $1.81 Mil.
Property, Plant and Equipment(Net PPE) was $0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.06 Mil.
Selling, General, & Admin. Expense(SGA) was $2.99 Mil.
Total Current Liabilities was $0.18 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(0.076 / 0.86)	/	(0.018 / 0.49)
	=	0.088372	/	0.036735
	=	2.4057

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(0.037 / 0.49)	/	(0.529 / 0.86)
	=	0.07551	/	0.615116
	=	0.1228

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (0.214 + 0.682) / 3.418)	/	(1 - (0.376 + 0.004) / 1.809)
	=	0.737858	/	0.789939
	=	0.9341

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	0.86	/	0.49
	=	1.7551

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(0.056 / (0.056 + 0.004))	/	(0.183 / (0.183 + 0.682))
	=	0.933333	/	0.211561
	=	4.4116

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(3.051 / 0.86)	/	(2.991 / 0.49)
	=	3.547674	/	6.104082
	=	0.5812

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((0.262 + 2.019) / 3.418)	/	((0 + 0.183) / 1.809)
	=	0.667349	/	0.101161
	=	6.5969

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(-2.787 - -0.152	-	-0.934)	/	3.418
	=	-0.497659

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Applied Biosciences has a M-score of -4.70 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →

What does a Beneish M-Score of 0.00 mean?

Applied Biosciences (APPB) has a Beneish M-Score of 0.00 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Applied Biosciences and its competitors.

Is Applied Biosciences' Beneish M-Score too high?

Applied Biosciences' current Beneish M-Score is 0.00. Overall, Applied Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.

How does Applied Biosciences' Beneish M-Score compare to CNABQ and OWCP?

Applied Biosciences' Beneish M-Score of 0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Beneish M-Score for a Drug Manufacturers company?

A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Beneish M-Score mean?

A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Applied Biosciences and its competitors. Applied Biosciences's current Beneish M-Score is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Applied Biosciences stock overvalued right now?

Applied Biosciences (APPB) has a current Beneish M-Score of 0.00. The current Beneish M-Score is 0.00. Applied Biosciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Beneish M-Score calculated?

Beneish M-Score is calculated from a company's financial statements. For Applied Biosciences (APPB), the current Beneish M-Score is 0.00 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Applied Biosciences Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies CNABQ OWCP CXUS CANB GSRX LITH GENH PCYN EVIO ACCA ZTS TSE:4502 XTER:MRK HKSE:03692 TSE:4523 SZSE:000661 TSE:4507 SZSE:000538 NSE:SUNPHARMA SZSE:300601

Address 112 North Curry Street, 18th Floor, Carson, NY, USA, 89703

Website https://www.appliedbiocorp.com

Applied Biosciences Corp is a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics / biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas. The company also deliver high-quality consumer and OTC THC-free CBD products that promote overall health and wellbeing as well as state-of-the-art testing and analytics capabilities to its customers.

12GF Score

Get the complete analysis for APPB

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00

Price

View APPB Analysis

See Beneish M-Score data for all stocks →